Literature DB >> 12395614

The efficacy of automated/electrical twitch obtaining intramuscular stimulation (atoims/etoims) for chronic pain control: evaluation with statistical process control methods.

J Chu1, D V Neuhauser, I Schwartz, H Htar Aye.   

Abstract

INTRODUCTION: Automated and/or electrical twitch-obtaining intramuscular stimulation (ATOIMS & ETOIMS) evoke twitches at/or near motor end plate zones to relieve muscle pain.
OBJECTIVES: To demonstrate that pain levels recorded daily by patients enable statistical process control (SPC) analysis of ATOIMS & ETOIMS effects over time.
METHODS: Four chronic fibromyalgic patients received ATOIMS & ETOIMS treatments to bilateral C3-C8 and L3-S1 myotomes and recorded daily pain on a visual analogue scale. Mechanical stimulation with ATOIMS involved a custom device to insert, oscillate and retract a monopolar needle (MN) at 2 Hz x2s. ETOIMS involved manual insertion of the MN and stimulating with 5 Volts, 0.5 ms pulse duration at 2 Hz for 2s to multiple sites. Positive outcome measures include two pain scales reduction.
RESULTS: Patient 1-4 had 89, 38, 40, 36 treatments during a follow-up time of 625, 1018, 378, 466 days with 5.4 +/- 3.7, 8.0 +/- 4.9, 4.2 +/- 2.4 and 4.6 +/- 2.7 days between treatments (DBT) during the first 6 months and 4.7 +/- 3.0, 21.8 +/- 15.6, 6.2 +/- 4.4 and 4.3 +/- 2.5 DBT respectively in the latter phase of the therapy. The average pain level (APL) in 1st week of treatment for patient 1-4 were 6.4 +/- 1.1, 3.7 +/- 1.1, 6.6 +/- 2.8 and 7.5 +/- 0.4 and in the last week of treatment were 4.5 +/- 0.4, 1.2 +/- 0.1, 4.2 +/- 1.0 and 4.7 +/- 0.7 respectively. APL correlated negatively with time during the first 6 months for patients 2-4 and also after 6 months for patients 4 & 1 who had unchanged and reduced DBT respectively. APL correlated positively with time for patient 2 with no correlation for patient 3 (both had increased DBT) after 6 months.
CONCLUSIONS: Patients will chronically record their pain scales daily enabling analysis by SPC. ATOIMS & ETOIMS applied periodically can be helpful in relieving fibromyalgic pain.

Entities:  

Mesh:

Year:  2002        PMID: 12395614

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  7 in total

1.  Chronic refractory myofascial pain and denervation supersensitivity as global public health disease.

Authors:  J Chu; F Bruyninckx; D V Neuhauser
Journal:  BMJ Case Rep       Date:  2016-01-13

Review 2.  Application of statistical process control in healthcare improvement: systematic review.

Authors:  Johan Thor; Jonas Lundberg; Jakob Ask; Jesper Olsson; Cheryl Carli; Karin Pukk Härenstam; Mats Brommels
Journal:  Qual Saf Health Care       Date:  2007-10

Review 3.  Brain manifestation and modulation of pain from myofascial trigger points.

Authors:  David M Niddam
Journal:  Curr Pain Headache Rep       Date:  2009-10

4.  Needling therapy for myofascial pain: recommended technique with multiple rapid needle insertion.

Authors:  Li-Wei Chou; Yueh-Ling Hsieh; Ta-Shen Kuan; Chang-Zern Hong
Journal:  Biomedicine (Taipei)       Date:  2014-08-02

5.  Probable mechanisms of needling therapies for myofascial pain control.

Authors:  Li-Wei Chou; Mu-Jung Kao; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

6.  Remote subcutaneous needling to suppress the irritability of myofascial trigger spots: an experimental study in rabbits.

Authors:  Zhonghua Fu; Yueh-Ling Hsieh; Chang-Zern Hong; Mu-Jung Kao; Jaung-Geng Lin; Li-Wei Chou
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-25       Impact factor: 2.629

7.  The protocol and design of a randomised controlled study on training of attention within the first year after acquired brain injury.

Authors:  Aniko Bartfai; Gabriela Markovic; Kristina Sargenius Landahl; Marie-Louise Schult
Journal:  BMC Neurol       Date:  2014-05-08       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.